Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
Britta Tjaden, Katharina Baum, Viktoria Marquardt, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

MYCN Function in Neuroblastoma Development
Jörg Otte, Cecilia Dyberg, Adena Pepich, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 127
MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma
Yuxiong Lu, Qing Yang, Yubin Su, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 119
A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor‐Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior
Liqun Ning, Jenny Shim, Martin L. Tomov, et al.
Advanced Science (2022) Vol. 9, Iss. 23
Open Access | Times Cited: 46
HER2 mediates clinical resistance to the KRASG12C inhibitor sotorasib, which is overcome by co-targeting SHP2
Cassandra Ho, Alicia I. Tüns, Hans‐Ulrich Schildhaus, et al.
European Journal of Cancer (2021) Vol. 159, pp. 16-23
Closed Access | Times Cited: 39
MYCN and Metabolic Reprogramming in Neuroblastoma
Mohit Bansal, Anamika Gupta, Han‐Fei Ding
Cancers (2022) Vol. 14, Iss. 17, pp. 4113-4113
Open Access | Times Cited: 23
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
Steffen Fuchs, Clara Danßmann, Filippos Klironomos, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy
Laura Grunewald, Lena Andersch, Konstantin Helmsauer, et al.
Pharmacological Research (2025) Vol. 212, pp. 107608-107608
Open Access
Immunometabolism: A ‘Hot’ Switch for ‘Cold’ Pediatric Solid Tumors
Lin Xiao, Harrison Yeung, Michelle Haber, et al.
Trends in cancer (2021) Vol. 7, Iss. 8, pp. 751-777
Open Access | Times Cited: 17
Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead
Sumana Shrestha, Alaide Morcavallo, Chiara Gorrini, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 16
Defining neuroblastoma: from origin to precision medicine
Lourdes Sainero‐Alcolado, Tomas Sjöberg Bexelius, Giuseppe Santopolo, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 12, pp. 2174-2192
Open Access | Times Cited: 2
Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma
Venugopal Gunda, Anup Singh Pathania, Srinivas Chava, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2576-2576
Open Access | Times Cited: 17
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma
Kai Voeltzke, Katerina Scharov, Cornelius M. Funk, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts
Haiwei Wang, Xinrui Wang, Liangpu Xu, et al.
BMC Pediatrics (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts
Luca Catalano, Sepideh Aminzadeh-Gohari, Daniela D. Weber, et al.
Metabolites (2023) Vol. 13, Iss. 8, pp. 910-910
Open Access | Times Cited: 5
MYCN inhibits TrkC-mediated differentiation in neuroblastoma cells via disruption of the PKA signalling pathway
Stephanie Maher, Kieran Wynne, Vadim Zhernovkov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Joint metabolomics and transcriptomics analysis systematically reveal the impact of MYCN in neuroblastoma
Bang Du, Yingyu Zhang, Pin Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Spliceosomal vulnerability of MYCN-amplified neuroblastoma is contingent on PRMT5-mediated regulation of epitranscriptomic and metabolomic pathways
Jodie Bojko, Madhu Kollareddy, Marianna Szemes, et al.
Cancer Letters (2024), pp. 217263-217263
Open Access | Times Cited: 1
Metabolic targeting of neuroblastoma, an update.
Leila Jahangiri
Cancer Letters (2024), pp. 217393-217393
Open Access | Times Cited: 1
NTRK1/TrkA Signaling in Neuroblastoma Cells Induces Nuclear Reorganization and Intra-Nuclear Aggregation of Lamin A/C
Lukas Funke, Thilo Bracht, Sebastian Oeck, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5293-5293
Open Access | Times Cited: 10
Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice
Roberto Avellino, Roger Mulet‐Lazaro, Marije Havermans, et al.
Blood Advances (2021) Vol. 6, Iss. 5, pp. 1406-1419
Open Access | Times Cited: 5
MYCL promotes the progression of triple‑negative breast cancer by activating the JAK/STAT3 pathway
Hongnan Jiang, Xiaojun Li, Wei Wang, et al.
Oncology Reports (2022) Vol. 48, Iss. 5
Open Access | Times Cited: 3
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy
Laura Grunewald, Lena Andersch, Konstantin Helmsauer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A Multi-Omics Approach Reveals Enrichment in Metabolites Involved in the Regulation of the Glutathione Pathway in LIN28B-Dependent Cancer Cells
Matteo Stocchero, Diana Corallo, Silvia Bresolin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1602-1602
Open Access
Glutamine addiction is targetable via altering splicing of nutrient sensors and epitranscriptome regulators
Jodie Bojko, Madhu Kollareddy, Marianna Szemes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A temporal (phospho-)proteomic dataset of neurotrophic receptor tyrosine kinase signalling in neuroblastoma
Stephanie Maher, Kieran Wynne, Vadim Zhernovkov, et al.
Scientific Data (2024) Vol. 11, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top